Physician profile
Micaela Moen
NPI 1760845168
$2,333.03
in general payments reported to CMS, 2019-2025
12 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2022: $135 · 2023: $177 · 2024: $1,737 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.31 |
| Travel and Lodging | $907.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,616.40 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Leica Microsystems INC. | $142.28 | 2022-2023 | Neoprobe |
| Atricure, INC. | $129.85 | 2023 | |
| Medtronic Vascular, INC. | $129.69 | 2020 | |
| Merck Sharp & Dohme LLC | $82.94 | 2025 | Lynparza, Keytruda |
| Merit Medical Systems INC | $48.07 | 2024 | Savi Scout |
| Medtronic, INC. | $39.62 | 2022 | |
| Davol INC. | $35.89 | 2025 | Arista |
| Becton, Dickinson and Company | $35.53 | 2025 | Arista |
| Elucent Medical | $28.40 | 2024 | |
| Hologic Sales and Service, LLC | $25.44 | 2024 | Localizer |
| Dilon Technologies, INC. | $18.92 | 2024 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micaela Moen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.